Staging of idiopathic pulmonary fibrosis: past, present and future

by Martin Kolb, Harold R. Collard
Published 2014-06-01

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management

by Justin M. Oldham, Harold R. Collard
Published 2017-08-01

Nintedanib in the treatment of idiopathic pulmonary fibrosis

by Mariano E. Mazzei, Luca Richeldi, Harold R. Collard
Published 2015-06-01

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

by Sergio Harari, Marc Humbert, Francesco Blasi, Harold R. Collard, Marco Matucci-Cerinic, Gerald Simonneau, Carlo Vancheri, Athol U. Wells, Vincent Cottin
Published 2015-09-01

miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.

by Supparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, Gary Green, Ram P Naikawadi, Kirk D Jones, Jeffrey A Golden, Aaron Schroeder, Michael A Matthay, Jasleen Kukreja, David J Erle, Harold R Collard, Paul J Wolters
Published 2016-01-01

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World

by Markus Polke, Yasuhiro Kondoh, Marlies Wijsenbeek, Vincent Cottin, Simon L. F. Walsh, Harold R. Collard, Nazia Chaudhuri, Sergey Avdeev, Jürgen Behr, Jürgen Behr, Gregory Calligaro, Tamera J. Corte, Kevin Flaherty, Manuela Funke-Chambour, Martin Kolb, Johannes Krisam, Toby M. Maher, Toby M. Maher, Maria Molina Molina, Maria Molina Molina, Antonio Morais, Catharina C. Moor, Julie Morisset, Carlos Pereira, Silvia Quadrelli, Silvia Quadrelli, Moises Selman, Argyrios Tzouvelekis, Claudia Valenzuela, Carlo Vancheri, Vanesa Vicens-Zygmunt, Julia Wälscher, Julia Wälscher, Wim Wuyts, Elisabeth Bendstrup, Michael Kreuter, Michael Kreuter
Published 2021-09-01